Efficacy, immunogenicity and safety of a recombinant tetravalent dengue vaccine (CYD-TDV) in children aged 2–17 years: systematic review and meta-analysis

BACKGROUND: Randomised controlled trials have evaluated the recombinant tetravalent dengue vaccine (CYD-TDV). However, individual results may have little power to identify differences among the populations studied. OBJECTIVE: To evaluate efficacy, immunogenicity and safety of CYD-TDV in the preventi...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMJ Open
Hlavní autoři: Rosa, Bruno Rodrigues, da Cunha, Antonio José Ledo Alves, Medronho, Roberto de Andrade
Médium: Artigo
Jazyk:Inglês
Vydáno: BMJ Publishing Group 2019
Témata:
Evidence Based Practice
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6429993/
https://ncbi.nlm.nih.gov/pubmed/30872537
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2017-019368
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky